You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endometrial Adenocarcinoma

Showing 26 - 50 of 3,799
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting
  • Advanced Solid Tumor
  • +15 more
  • (no location specified)
Jun 2, 2023

Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily

Recruiting
  • Solid Tumor
  • +8 more
  • TPST-1495 twice daily
  • +2 more
  • Baltimore, Maryland
  • +8 more
Jan 4, 2023

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Endometrial Cancer Who Receive Standard Treatment for Their

Recruiting
  • Endometrial Cancer
  • +2 more
  • Physical exam
  • Hartford, Connecticut
  • +19 more
Jan 19, 2023

Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

Available
  • Esophageal Neoplasm
  • +9 more
  • Birmingham, Alabama
  • +3 more
Aug 24, 2022

Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

Not yet recruiting
  • Ovarian Neoplasms
  • +5 more
  • (no location specified)
Sep 3, 2023

Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid

Recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Greeley, Colorado
  • +17 more
Jun 13, 2022

NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

Recruiting
  • Non-small Cell Lung Cancer
  • +10 more
  • Grand Rapids, Michigan
  • +2 more
Apr 25, 2023

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)

Recruiting
  • Adenocarcinoma of Endometrium
  • Basking Ridge, New Jersey
  • +6 more
Oct 12, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin

Active, not recruiting
  • Breast Carcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 28, 2022

Esophageal Adenocarcinoma, Esophagus SCC, Cholangiocarcinoma Trial in Belgium, France (Abemaciclib)

Active, not recruiting
  • Esophageal Adenocarcinoma
  • +4 more
  • Antwerpen, Belgium
  • +10 more
May 27, 2022

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

SCCOHT, Ovarian Clear Cell Tumor, Ovarian Endometrioid Adenocarcinoma Trial in Scottsdale (SP-2577, Pembrolizumab)

Withdrawn
  • SCCOHT
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 11, 2022

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer Trial in Canada,

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Baltimore, Maryland
  • +6 more
Apr 25, 2022

Advanced Endometrial Adenocarcinoma, Stage III A, B, C Trial in Greenville, Roanoke (Docetaxel and Carboplatin)

Terminated
  • Advanced Endometrial Adenocarcinoma, Stage III A, B, C
  • Docetaxel and Carboplatin
  • Greenville, South Carolina
  • +1 more
Feb 3, 2021

Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,

Recruiting
  • Advanced Solid Tumors
  • +11 more
  • Boston, Massachusetts
  • +4 more
Dec 12, 2022

Ovarian Clear Cell Adenocarcinoma, Platinum-Sensitive Ovarian Carcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in

Not yet recruiting
  • Ovarian Clear Cell Adenocarcinoma
  • +14 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +4 more
  • Buffalo, New York
  • +1 more
Dec 16, 2022

Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Bronx (drug, radiation,

Terminated
  • Endometrial Adenocarcinoma
  • +8 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Carcinoma, Endometrial Adenocarcinoma, Tumors Trial in United States (PEN-866 Sodium, fluorouracil, Folinic acid)

Recruiting
  • Carcinoma
  • +18 more
  • PEN-866 Sodium
  • +3 more
  • Springdale, Arkansas
  • +15 more
Feb 16, 2022

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023

Solid Tumor, NSCLC, Cervical Cancer Trial in China (Afuresertib, Nab paclitaxel, Docetaxel)

Recruiting
  • Solid Tumor
  • +5 more
  • Beijing, Beijing, China
  • +4 more
Jul 15, 2022

Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

Active, not recruiting
  • Uterine Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +7 more
Apr 4, 2022